News

Published on 22 Nov 2024 on Zacks · via Yahoo Finance

Cencora Rallies 19.7% Year to Date: What's Driving the Stock?


Article preview image

These factors are likely to have favored the stock’s growth. Risk Factors COR’s gross margin...

NYSE.COR price evolution
NASDAQ.ANGO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Cencora Rallies 19.7% Year to Date: What's Driving the Stock?

These factors are likely to have favored the stock’s growth. Risk Factors COR’s gross margin...

Zacks · via Yahoo Finance 22 Nov 2024

DexCom and OURA Ink Partnership for Metabolic Health Innovation

DexCom, Inc. Price DexCom, Inc. price | DexCom, Inc. Quote Recent Developments Last month, DexCom...

Zacks · via Yahoo Finance 22 Nov 2024

GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects

GE HealthCare's Portrait Mobile solution will provide continuous monitoring in post-surgery...

Zacks · via Yahoo Finance 21 Nov 2024

Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now

WST continues to gain momentum due to its strength in the Pharma market unit. However, decline...

Zacks · via Yahoo Finance 19 Nov 2024

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

Intelligent Bio Solutions unveils strong initial results for its PK study, which is important for...

Zacks 17 Nov 2024

AngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To Expect

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q1 2025 earnings on Oct 3, 2024. The consen...

GuruFocus.com · via Yahoo Finance 29 Sep 2024

Insider Spends US$67k Buying More Shares In AngioDynamics

Even if it's not a huge purchase, we think it was good to see that James Clemmer, the CEO, Presid...

Simply Wall St. via Yahoo Finance 10 Apr 2024

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript April 4, 2024 AngioDynamics, I...

Insider Monkey via Yahoo Finance 8 Apr 2024

AngioDynamics CEO buys $67,000 worth of company stock By Investing.com

In a recent transaction, James C. Clemmer, President and CEO of AngioDynamics Inc (NASDAQ:ANGO),...

Investing.com 8 Apr 2024

AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 16 cents for third-quarter fiscal...

Zacks via Yahoo Finance 5 Apr 2024